Nothing Special   »   [go: up one dir, main page]

GB201607801D0 - Combination therapy using inhibitors of human Growth and Differentiation Factor 15 (GDF-15) and immune checkpoint blockers - Google Patents

Combination therapy using inhibitors of human Growth and Differentiation Factor 15 (GDF-15) and immune checkpoint blockers

Info

Publication number
GB201607801D0
GB201607801D0 GBGB1607801.6A GB201607801A GB201607801D0 GB 201607801 D0 GB201607801 D0 GB 201607801D0 GB 201607801 A GB201607801 A GB 201607801A GB 201607801 D0 GB201607801 D0 GB 201607801D0
Authority
GB
United Kingdom
Prior art keywords
gdf
inhibitors
combination therapy
immune checkpoint
human growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1607801.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Julius Maximilians Universitaet Wuerzburg
Original Assignee
Julius Maximilians Universitaet Wuerzburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Julius Maximilians Universitaet Wuerzburg filed Critical Julius Maximilians Universitaet Wuerzburg
Priority to GBGB1607801.6A priority Critical patent/GB201607801D0/en
Publication of GB201607801D0 publication Critical patent/GB201607801D0/en
Priority to CN201680071106.8A priority patent/CN108463246A/en
Priority to HUE16778750A priority patent/HUE060762T2/en
Priority to JP2018516739A priority patent/JP6925326B2/en
Priority to CN202410060871.6A priority patent/CN117883572A/en
Priority to PL16778750.6T priority patent/PL3355919T3/en
Priority to AU2016333539A priority patent/AU2016333539B2/en
Priority to HRP20221530TT priority patent/HRP20221530T1/en
Priority to BR112018006218A priority patent/BR112018006218A2/en
Priority to MDE20180766T priority patent/MD3355919T2/en
Priority to IL299478A priority patent/IL299478A/en
Priority to DK16778750.6T priority patent/DK3355919T5/en
Priority to SM20230017T priority patent/SMT202300017T1/en
Priority to PT167787506T priority patent/PT3355919T/en
Priority to FIEP16778750.6T priority patent/FI3355919T3/en
Priority to EP16778750.6A priority patent/EP3355919B1/en
Priority to LTEPPCT/EP2016/073520T priority patent/LT3355919T/en
Priority to KR1020187012421A priority patent/KR102722730B1/en
Priority to EA201890850A priority patent/EA201890850A1/en
Priority to CA3000293A priority patent/CA3000293A1/en
Priority to EP22203233.6A priority patent/EP4218809A3/en
Priority to SI201631649T priority patent/SI3355919T1/en
Priority to ES16778750T priority patent/ES2937167T3/en
Priority to US15/765,176 priority patent/US11464856B2/en
Priority to PCT/EP2016/073520 priority patent/WO2017055613A2/en
Priority to IL258393A priority patent/IL258393B2/en
Priority to HK18115128.3A priority patent/HK1256067A1/en
Priority to JP2021123302A priority patent/JP7443298B2/en
Priority to US17/823,383 priority patent/US20230093412A1/en
Priority to AU2023202602A priority patent/AU2023202602A1/en
Priority to JP2024017520A priority patent/JP2024054251A/en
Ceased legal-status Critical Current

Links

GBGB1607801.6A 2015-10-02 2016-04-29 Combination therapy using inhibitors of human Growth and Differentiation Factor 15 (GDF-15) and immune checkpoint blockers Ceased GB201607801D0 (en)

Priority Applications (31)

Application Number Priority Date Filing Date Title
GBGB1607801.6A GB201607801D0 (en) 2016-04-29 2016-04-29 Combination therapy using inhibitors of human Growth and Differentiation Factor 15 (GDF-15) and immune checkpoint blockers
PCT/EP2016/073520 WO2017055613A2 (en) 2015-10-02 2016-09-30 Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockers
FIEP16778750.6T FI3355919T3 (en) 2015-10-02 2016-09-30 Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockers
KR1020187012421A KR102722730B1 (en) 2015-10-02 2016-09-30 Combination therapy using inhibitors of human proliferation and differentiation factor 15 (GDF-15) and immune checkpoint blockers
EP16778750.6A EP3355919B1 (en) 2015-10-02 2016-09-30 Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockers
CN202410060871.6A CN117883572A (en) 2015-10-02 2016-09-30 Human GDF-15 inhibitor, composition and kit containing same and application thereof
PL16778750.6T PL3355919T3 (en) 2015-10-02 2016-09-30 Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockers
AU2016333539A AU2016333539B2 (en) 2015-10-02 2016-09-30 Combination therapy using inhibitors of human Growth and Differentiation Factor 15 (GDF-15) and immune checkpoint blockers
HRP20221530TT HRP20221530T1 (en) 2015-10-02 2016-09-30 Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockers
BR112018006218A BR112018006218A2 (en) 2015-10-02 2016-09-30 hgdf-15 inhibitors, their uses, composition, kit, combinations and in vitro method for determining whether a substance of interest is an hgdf-15 inhibitor
MDE20180766T MD3355919T2 (en) 2015-10-02 2016-09-30 Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers
IL299478A IL299478A (en) 2015-10-02 2016-09-30 Combined treatment using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint inhibitors
DK16778750.6T DK3355919T5 (en) 2015-10-02 2016-09-30 COMBINATION THERAPY USING HUMAN GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15) INHIBITORS AND IMMUNE CHECKPOINT BLOCKERS
SM20230017T SMT202300017T1 (en) 2015-10-02 2016-09-30 Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockers
PT167787506T PT3355919T (en) 2015-10-02 2016-09-30 Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockers
CN201680071106.8A CN108463246A (en) 2015-10-02 2016-09-30 User's growth and differentiation factor 15 (GDF-15) inhibitor and immunologic test order the combination therapy of blocking agent
JP2018516739A JP6925326B2 (en) 2015-10-02 2016-09-30 Combination therapy using inhibitors of human growth differentiation factor 15 (GDF-15) and immune checkpoint blockers
LTEPPCT/EP2016/073520T LT3355919T (en) 2015-10-02 2016-09-30 Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockers
US15/765,176 US11464856B2 (en) 2015-10-02 2016-09-30 Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers
EA201890850A EA201890850A1 (en) 2015-10-02 2016-09-30 COMBINED TREATMENT WITH THE USE OF HUMAN INHIBITORS OF GROWTH AND DIFFERENTIATION 15 (GDF-15) AND IMMUNE RESPONSE CONTROL POINTERS
CA3000293A CA3000293A1 (en) 2015-10-02 2016-09-30 Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockers
EP22203233.6A EP4218809A3 (en) 2015-10-02 2016-09-30 Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockers
SI201631649T SI3355919T1 (en) 2015-10-02 2016-09-30 Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockers
ES16778750T ES2937167T3 (en) 2015-10-02 2016-09-30 Combination therapy using human growth and differentiation factor-15 (GDF-15) inhibitors and immune checkpoint blockers
HUE16778750A HUE060762T2 (en) 2015-10-02 2016-09-30 Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockers
IL258393A IL258393B2 (en) 2015-10-02 2018-03-27 Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockers
HK18115128.3A HK1256067A1 (en) 2015-10-02 2018-11-27 Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockers
JP2021123302A JP7443298B2 (en) 2015-10-02 2021-07-28 Combination therapy using inhibitors of human growth differentiation factor 15 (GDF-15) and immune checkpoint blockers
US17/823,383 US20230093412A1 (en) 2015-10-02 2022-08-30 Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockers
AU2023202602A AU2023202602A1 (en) 2015-10-02 2023-04-28 Combination therapy using inhibitors of human Growth and Differentiation factor 15 (GDF-15) and immune checkpoint blockers
JP2024017520A JP2024054251A (en) 2015-10-02 2024-02-07 Combination therapy using an inhibitor of human growth differentiation factor 15 (GDF-15) and an immune checkpoint blocker

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1607801.6A GB201607801D0 (en) 2016-04-29 2016-04-29 Combination therapy using inhibitors of human Growth and Differentiation Factor 15 (GDF-15) and immune checkpoint blockers

Publications (1)

Publication Number Publication Date
GB201607801D0 true GB201607801D0 (en) 2016-06-15

Family

ID=56234380

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1607801.6A Ceased GB201607801D0 (en) 2015-10-02 2016-04-29 Combination therapy using inhibitors of human Growth and Differentiation Factor 15 (GDF-15) and immune checkpoint blockers

Country Status (1)

Country Link
GB (1) GB201607801D0 (en)

Similar Documents

Publication Publication Date Title
HK1256067A1 (en) Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockers
IL272137A (en) Interleukin-21 muteins and methods of treatment
IL285019A (en) Transponders and sensors for implantable medical devices and methods of using them
IL273918A (en) Trispecific proteins and methods of use
IL262831A (en) Medical implants and methods of preparation thereof
GB2519302B (en) Apparatus for artificial cardiac stimulation and method of using the same
HK1218122A1 (en) Co rti statin analogues for the treatment of inflammatory and or immune diseases
HK1254954A1 (en) Lpt-723 and immune checkpoint inhibitor combinations and methods of treatment
IL270894A (en) Human antibodies to bet v 1 and methods of use thereof
HK1249460A1 (en) Implant applicators and methods of administering implants
IL283916A (en) Antibodies to human complement factor c2b and methods of use
GB201607801D0 (en) Combination therapy using inhibitors of human Growth and Differentiation Factor 15 (GDF-15) and immune checkpoint blockers
GB201517531D0 (en) Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)